Does faster aspart improve time in range in children with type 1 diabetes with glycaemia close to target on insulin pump therapy?

Documenti analoghi

• Sensor‐derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster acting insulin aspart or insulin aspart—A secondary analysis of the CopenFast trial
  di: Julie C. Søholm, et al.
  Pubblicazione: (2024)
• Hybrid closed‐loop insulin delivery improves glycaemic control compared with sensor‐augmented pump therapy: A meta‐analysis of ‘free‐living’ randomised trials in type 1 diabetes
  di: Amardeep S. Sidki, et al.
  Pubblicazione: (2026)
• Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery
  di: Klemen Dovč, et al.
  Pubblicazione: (2025)
• Glycaemic outcomes of a 4‐h insulin pump suspension for prolonged exercise in youth with type 1 diabetes
  di: Andrea E. Scaramuzza, et al.
  Pubblicazione: (2025)
• Weight loss is associated with improved daytime time in range in adults with prediabetes and non‐insulin‐treated type 2 diabetes undergoing dietary intervention
  di: Souptik Barua, et al.
  Pubblicazione: (2025)